AR047155A1 - METODO PARA LA PREPARACION DE UNA FORMA DE DOSIFICACIoN SOLIDA DE DESMOPRESINA - Google Patents
METODO PARA LA PREPARACION DE UNA FORMA DE DOSIFICACIoN SOLIDA DE DESMOPRESINAInfo
- Publication number
- AR047155A1 AR047155A1 ARP040104760A ARP040104760A AR047155A1 AR 047155 A1 AR047155 A1 AR 047155A1 AR P040104760 A ARP040104760 A AR P040104760A AR P040104760 A ARP040104760 A AR P040104760A AR 047155 A1 AR047155 A1 AR 047155A1
- Authority
- AR
- Argentina
- Prior art keywords
- solid dosage
- preparation
- dosage form
- desmopresin
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Método para la preparacion de una forma de dosificacion solida de desmopresina, o una sal farmacéuticamente aceptable de la misma, el cual comprende proporcionar un granulado que contiene desmopresina adecuado para comprimirse hasta formar una tableta farmacéuticamente aceptable, así como a formas de dosificacion solidas, de preferencia tabletas, que se pueden obtener mediante este método.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03029897A EP1550439B1 (en) | 2003-12-29 | 2003-12-29 | Method for preparing a solid dosage form of desmopressin |
Publications (1)
Publication Number | Publication Date |
---|---|
AR047155A1 true AR047155A1 (es) | 2006-01-11 |
Family
ID=34560171
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP040104760A AR047155A1 (es) | 2003-12-29 | 2004-12-17 | METODO PARA LA PREPARACION DE UNA FORMA DE DOSIFICACIoN SOLIDA DE DESMOPRESINA |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1550439B1 (es) |
AR (1) | AR047155A1 (es) |
AT (1) | ATE319430T1 (es) |
DE (1) | DE60303872T2 (es) |
DK (1) | DK1550439T3 (es) |
ES (1) | ES2254858T3 (es) |
HK (1) | HK1079696A1 (es) |
IL (3) | IL189107A0 (es) |
NO (1) | NO20045657L (es) |
PT (1) | PT1550439E (es) |
SI (1) | SI1550439T1 (es) |
TW (1) | TWI282284B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0210397D0 (en) | 2002-05-07 | 2002-06-12 | Ferring Bv | Pharmaceutical formulations |
SE528446C2 (sv) * | 2006-03-02 | 2006-11-14 | Ferring Int Ct Sa | Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse |
CA2584456C (en) * | 2006-03-02 | 2008-07-22 | Ferring International Center S.A. | Composition comprising desmopressin |
US20100286045A1 (en) | 2008-05-21 | 2010-11-11 | Bjarke Mirner Klein | Methods comprising desmopressin |
US11963995B2 (en) | 2008-05-21 | 2024-04-23 | Ferring B.V. | Methods comprising desmopressin |
LT3225250T (lt) | 2008-05-21 | 2019-11-11 | Ferring Bv | Burnoje disperguojamas desmopresinas, skirtas nikturijos nepertraukiamo miego pirminio periodo pailginimui |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1677095A (en) * | 1994-01-11 | 1995-08-01 | Alkermes Controlled Therapeutics, Inc. | Oral dosage form of desmopressin (ddavp) |
KR20040047915A (ko) * | 2001-10-15 | 2004-06-05 | 룀 게엠베하 운트 콤파니 카게 | 활성제로서 펩타이드 또는 단백질을 함유하는 생약 형태를제조하기 위한 공중합체의 용도 |
DE60307082D1 (de) * | 2002-05-07 | 2006-09-07 | Ferring Bv | In der mundhöhle dispergierbare phamarzeutische zusammensetzung mit desmopressin |
-
2003
- 2003-12-29 EP EP03029897A patent/EP1550439B1/en not_active Revoked
- 2003-12-29 DE DE60303872T patent/DE60303872T2/de not_active Expired - Lifetime
- 2003-12-29 ES ES03029897T patent/ES2254858T3/es not_active Expired - Lifetime
- 2003-12-29 AT AT03029897T patent/ATE319430T1/de active
- 2003-12-29 DK DK03029897T patent/DK1550439T3/da active
- 2003-12-29 PT PT03029897T patent/PT1550439E/pt unknown
- 2003-12-29 SI SI200330252T patent/SI1550439T1/sl unknown
-
2004
- 2004-12-15 IL IL189107A patent/IL189107A0/en unknown
- 2004-12-15 IL IL202881A patent/IL202881A0/en unknown
- 2004-12-15 IL IL16578004A patent/IL165780A0/xx unknown
- 2004-12-17 AR ARP040104760A patent/AR047155A1/es not_active Application Discontinuation
- 2004-12-27 TW TW093140752A patent/TWI282284B/zh not_active IP Right Cessation
- 2004-12-27 NO NO20045657A patent/NO20045657L/no not_active Application Discontinuation
-
2005
- 2005-12-23 HK HK05111933A patent/HK1079696A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
TW200528141A (en) | 2005-09-01 |
NO20045657D0 (no) | 2004-12-27 |
ES2254858T3 (es) | 2006-06-16 |
EP1550439B1 (en) | 2006-03-08 |
HK1079696A1 (en) | 2006-04-13 |
PT1550439E (pt) | 2006-06-30 |
ATE319430T1 (de) | 2006-03-15 |
SI1550439T1 (sl) | 2006-08-31 |
NO20045657L (no) | 2005-06-30 |
DK1550439T3 (da) | 2006-04-03 |
EP1550439A1 (en) | 2005-07-06 |
IL165780A0 (en) | 2006-01-15 |
IL189107A0 (en) | 2008-06-05 |
IL202881A0 (en) | 2011-07-31 |
DE60303872D1 (de) | 2006-05-04 |
TWI282284B (en) | 2007-06-11 |
DE60303872T2 (de) | 2006-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2008003298A1 (es) | Forma de dosificacion oral solida que comprende a) un compuesto de accion doble en concentracion entre 4 y 90%, b) un excipiente farmaceuticamente aceptable; proceso de preparación; uso en el tratamiento de enfermedades cardiovasculares y/o renales. | |
CY1126116T1 (el) | Φαρμακευτικες συνθεσεις αποτελουμενες απο νιλοτινιμπη | |
EA201200937A1 (ru) | Твердая лекарственная форма тикагрелора | |
BRPI0606339A2 (pt) | formas farmacêuticas resistentes a álcool | |
HN2006014095A (es) | Forma cristalina ortorrombica del maleato de asenapina | |
ECSP088188A (es) | Formas de dosis sólidas de valsartan y amlodipina y método para hacer las mismas | |
ATE427965T1 (de) | Antikírper gegen 25-hydroxyvitamin d | |
MX2009011588A (es) | Formas de dosificacion solidas que comprenden tadalafil. | |
NL1031626A1 (nl) | Verbindingen die bruikbaar zijn in therapie. | |
EA200802324A1 (ru) | Новая форма введения рацекадотрила | |
CY1110097T1 (el) | Διπλοστοιβαδικο δισκιο για προληψη καρδιαγγειακων συμβαντων | |
EA200601759A1 (ru) | Композиции рамиприла | |
PL1888514T3 (pl) | Sole podstawionych estrów kwasu alofanowego i ich zastosowanie w środkach leczniczych | |
WO2006123243A3 (en) | Pharmaceutical dosage forms comprising escitalopram in form of granules | |
DK1670778T3 (da) | Omlejrede pentanoler, en fremgangsmåde til fremstilling heraf og anvendelse heraf som betændelsehæmmende | |
NO20055207L (no) | Oralt farmasoytisk preparat for protonpumpeantagonister | |
IS8185A (is) | Aðferð til þess að búa til afleiður spíróbenzóazepíns sem eru ekki setnar með peptíði | |
BR122016006880B8 (pt) | forma de dosagem contendo pantoprazol como ingrediente ativo | |
AR047155A1 (es) | METODO PARA LA PREPARACION DE UNA FORMA DE DOSIFICACIoN SOLIDA DE DESMOPRESINA | |
EA201200727A1 (ru) | Фармацевтическая композиция, содержащая гидрохлорид донепезила, полученная из нее таблетка и способ ее получения | |
EA200970816A1 (ru) | Новая лекарственная форма | |
CL2004000984A1 (es) | Forma de dosificacion oral de una sal de magnesio de (s)-pantopazol, para la profilaxis o tratamiento de una condicion asociada a inhibir la bomba protonica. | |
ITMI20030341A1 (it) | Sistema per controllare la fabbricazione di una molla. | |
EA201190282A1 (ru) | Фармацевтическая композиция, содержащая тамсулозин | |
UY28677A1 (es) | Método para la preparación de una forma de dosificación sólida de desmopresina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |